<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Regulatory actions</title>
    <description></description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Regulatory actions for June 10, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atavistik, Chiesi, Disc, Gen1e, Matisse, Personalis, Redhill, Vertanical, Xenix, Zai Lab.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atavistik, Chiesi, Disc, Gen1e, Matisse, Personalis, Redhill, Vertanical, Xenix, Zai Lab.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731731</guid>
      <pubDate>Wed, 10 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731731-regulatory-actions-for-june-10-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 9, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Artiva, Intrabio, Oncolys, Pfizer, Sanofi, Vcare, Vor, Remegen, Xspray.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Artiva, Intrabio, Oncolys, Pfizer, Sanofi, Vcare, Vor, Remegen, Xspray.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731717</guid>
      <pubDate>Tue, 09 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731717-regulatory-actions-for-june-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 9, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Haisco, Innovent, Iovance, Lupeng, Lupin, Nxera, Quoin, Reach Surgical, Santhera, Shionogi, Wockhardt.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Haisco, Innovent, Iovance, Lupeng, Lupin, Nxera, Quoin, Reach Surgical, Santhera, Shionogi, Wockhardt.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731797</guid>
      <pubDate>Tue, 09 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731797-regulatory-actions-for-june-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 8, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Chiesi, Lupin, Tandem.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Chiesi, Lupin, Tandem.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731703</guid>
      <pubDate>Mon, 08 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731703-regulatory-actions-for-june-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 5, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Amneal, Attralus, Biogen, GE, Innovent, Iovance, Kashiv, Lupeng, Mammotome, Pharming, Quoin, Verastem, Xbrane, Zepto.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Amneal, Attralus, Biogen, GE, Innovent, Iovance, Kashiv, Lupeng, Mammotome, Pharming, Quoin, Verastem, Xbrane, Zepto.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731642</guid>
      <pubDate>Fri, 05 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731642-regulatory-actions-for-june-5-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 4, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731628</guid>
      <pubDate>Thu, 04 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731628-regulatory-actions-for-june-4-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 3, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Amgen, Foundation, Intelligent, Johnson, Merakris, Nxera, Pasithea, Roche, Santhera.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Amgen, Foundation, Intelligent, Johnson, Merakris, Nxera, Pasithea, Roche, Santhera.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731551</guid>
      <pubDate>Wed, 03 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731551-regulatory-actions-for-june-3-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 2, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, Cercare, Foundation, Haisco, Kamada, Mannkind, Nouscom, Outlook, Polypid, Shionogi, Surgentec, Vertex, Wockhardt.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, Cercare, Foundation, Haisco, Kamada, Mannkind, Nouscom, Outlook, Polypid, Shionogi, Surgentec, Vertex, Wockhardt.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731537</guid>
      <pubDate>Tue, 02 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731537-regulatory-actions-for-june-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 2, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Boehringer Ingelheim, Cornerstone Robotics, Daiichi Sankyo, Dizal, Gene Solutions, H. Lundbeck, Innocare, Optimi Health, Skia, Vanda, Zydus.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Boehringer Ingelheim, Cornerstone Robotics, Daiichi Sankyo, Dizal, Gene Solutions, H. Lundbeck, Innocare, Optimi Health, Skia, Vanda, Zydus.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731615</guid>
      <pubDate>Tue, 02 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731615-regulatory-actions-for-june-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 1, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Coredio, Johnson, Merck, Neuropace, Optimi, Replimune, Skia, Spectral, Tempus, Zydus.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Coredio, Johnson, Merck, Neuropace, Optimi, Replimune, Skia, Spectral, Tempus, Zydus.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731523</guid>
      <pubDate>Mon, 01 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731523-regulatory-actions-for-june-1-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 29, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Beren, Cogent, Corcept, Enterome, Gene Solutions, Innocare, Ironwood, Renovorx, Sanofi, Solu, Zenas.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Beren, Cogent, Corcept, Enterome, Gene Solutions, Innocare, Ironwood, Renovorx, Sanofi, Solu, Zenas.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731465</guid>
      <pubDate>Fri, 29 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731465-regulatory-actions-for-may-29-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 28, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Bridgebio, Cardiosense, Corcept, Dizal, Innocare, Nuvalent, Precigen, Senzime, Subtle, Vanda.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Bridgebio, Cardiosense, Corcept, Dizal, Innocare, Nuvalent, Precigen, Senzime, Subtle, Vanda.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731451</guid>
      <pubDate>Thu, 28 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731451-regulatory-actions-for-may-28-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 27, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Autobahn, Cornerstone, Dyne, Gilead, H. Lundbeck, Microbot, Outlook, Pfizer, Pharming, Spectral, Toby.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Autobahn, Cornerstone, Dyne, Gilead, H. Lundbeck, Microbot, Outlook, Pfizer, Pharming, Spectral, Toby.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731430</guid>
      <pubDate>Wed, 27 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731430-regulatory-actions-for-may-27-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 26, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Agios, Astellas, Astrazeneca, Boehringer, Daiichi, Gilead, Merck, Novo, Regeneron, Teva.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Agios, Astellas, Astrazeneca, Boehringer, Daiichi, Gilead, Merck, Novo, Regeneron, Teva.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731416</guid>
      <pubDate>Tue, 26 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731416-regulatory-actions-for-may-26-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 26, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo, GSK, H. Lundbeck, Hutchmed, Innovent, Junshi, Lupin, Maat, Mabwell.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo, GSK, H. Lundbeck, Hutchmed, Innovent, Junshi, Lupin, Maat, Mabwell.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731436</guid>
      <pubDate>Tue, 26 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731436-regulatory-actions-for-may-26-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 22, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adagio, Bayer, Hutchmed, Innovent, Junshi, Leo Cancer, Maat, Mabwell.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adagio, Bayer, Hutchmed, Innovent, Junshi, Leo Cancer, Maat, Mabwell.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731398</guid>
      <pubDate>Fri, 22 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731398-regulatory-actions-for-may-22-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 21, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Diasorin, Guardant, Immunitybio, Implantica.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Diasorin, Guardant, Immunitybio, Implantica.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731383</guid>
      <pubDate>Thu, 21 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731383-regulatory-actions-for-may-21-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 20, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Bayer, Belite Bio, Cullinan, Intrabio, Lupin, Galvanize, Portal Access, Sunrise.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Bayer, Belite Bio, Cullinan, Intrabio, Lupin, Galvanize, Portal Access, Sunrise.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731351</guid>
      <pubDate>Wed, 20 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731351-regulatory-actions-for-may-20-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 19, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord Biopharma, Acist, Astrazeneca, Boehringer Ingelheim, Daiichi, Genentech, GSK, H. Lundbeck, Krystal, Natera, Vertanical, Viatris.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord Biopharma, Acist, Astrazeneca, Boehringer Ingelheim, Daiichi, Genentech, GSK, H. Lundbeck, Krystal, Natera, Vertanical, Viatris.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731337</guid>
      <pubDate>Tue, 19 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731337-regulatory-actions-for-may-19-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 19, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Fujirebio, Gyre, H.U. Group, Innovent, Kyowa Kirin, Shionogi, Taiho, Taiho Oncology, Viiv Healthcare, Zai Lab, Zhejiang Wenda.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Fujirebio, Gyre, H.U. Group, Innovent, Kyowa Kirin, Shionogi, Taiho, Taiho Oncology, Viiv Healthcare, Zai Lab, Zhejiang Wenda.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731361</guid>
      <pubDate>Tue, 19 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731361-regulatory-actions-for-may-19-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 18, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Sandoz, Valar Labs.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Sandoz, Valar Labs.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731323</guid>
      <pubDate>Mon, 18 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731323-regulatory-actions-for-may-18-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 15, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alloplex, Beone, Clearpoint, Glooko, Inmune, Kyowa Kirin, Taiho, Taiho Oncology.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alloplex, Beone, Clearpoint, Glooko, Inmune, Kyowa Kirin, Taiho, Taiho Oncology.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731220</guid>
      <pubDate>Fri, 15 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731220-regulatory-actions-for-may-15-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 14, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cepheid, Epineuron, Femasys, Gyre, Kyverna, Pfizer, Revvity, Siemens.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cepheid, Epineuron, Femasys, Gyre, Kyverna, Pfizer, Revvity, Siemens.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731206</guid>
      <pubDate>Thu, 14 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731206-regulatory-actions-for-may-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 13, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Bayesian, Coya, Eli Lilly, Roche.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Bayesian, Coya, Eli Lilly, Roche.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731071</guid>
      <pubDate>Wed, 13 May 2026 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731071-regulatory-actions-for-may-13-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 12, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apyx, Argenx, Biozen, Corvention, Fujirebio, H.U. Group Holdings, Innovent, Partner, Shionogi, Sironax, Transpire, Viiv, Zai Lab, Zhejiang Wenda.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apyx, Argenx, Biozen, Corvention, Fujirebio, H.U. Group Holdings, Innovent, Partner, Shionogi, Sironax, Transpire, Viiv, Zai Lab, Zhejiang Wenda.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731057</guid>
      <pubDate>Tue, 12 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731057-regulatory-actions-for-may-12-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 12, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Chance, Eisai, Kelun-Biotech, Lanexa, Mezzion, Norgine, Rznomics, Specialised, Sunshine Lake, Ultragreen.ai.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Chance, Eisai, Kelun-Biotech, Lanexa, Mezzion, Norgine, Rznomics, Specialised, Sunshine Lake, Ultragreen.ai.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731118</guid>
      <pubDate>Tue, 12 May 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731118-regulatory-actions-for-may-12-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 11, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, BMS, Chance, Eisai, Kelun-Biotech, Mezzion, Rivanna, Rznomics.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, BMS, Chance, Eisai, Kelun-Biotech, Mezzion, Rivanna, Rznomics.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731043</guid>
      <pubDate>Mon, 11 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731043-regulatory-actions-for-may-11-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 8, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Armata, Atara, Bright Uro, Microsure, Partner, Repertoire.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Armata, Atara, Bright Uro, Microsure, Partner, Repertoire.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/730991</guid>
      <pubDate>Fri, 08 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730991-regulatory-actions-for-may-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 7, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artera, Bridgebio, Diakonos, Norgine, Nuvation.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artera, Bridgebio, Diakonos, Norgine, Nuvation.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/730977</guid>
      <pubDate>Thu, 07 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730977-regulatory-actions-for-may-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 6, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Clear Scientific, Fate, Multi4, Neurocare, Opus Genetics, Ultragreen.ai.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Clear Scientific, Fate, Multi4, Neurocare, Opus Genetics, Ultragreen.ai.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/730873</guid>
      <pubDate>Wed, 06 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730873-regulatory-actions-for-may-6-2026</link>
    </item>
  </channel>
</rss>
